Doctors Recommend Control Cholesterol Levels.
Keeping "bad" cholesterol in halt and increasing "good" cholesterol is not only reputable for your heart, but also your brain, new research suggests. A burn the midnight oil from the University of California, Davis, found that low levels of "bad" (LDL) cholesterol and extreme levels of "good" (HDL) cholesterol are linked to lower levels of so-called amyloid marker in the brain phallosan forte vorher nachher bilder. A build-up of this plaque is an indication of Alzheimer's disease, the researchers said in a university tidings release.
The researchers suggested that maintaining healthy cholesterol levels is just as important for perception health as controlling blood pressure. "Our study shows that both higher levels of HDL and downgrade levels of LDL cholesterol in the bloodstream are associated with lower levels of amyloid medal deposits in the brain," the study's lead author, Bruce Reed, associate director of the UC Davis Alzheimer's Disease Center, said in the bulletin release click here. "Unhealthy patterns of cholesterol could be later causing the higher levels of amyloid known to contribute to Alzheimer's, in the same way that such patterns speak for heart disease".
The study, which was published in the Dec 30, 2013 online version of the journal JAMA Neurology, involved 74 men and women recruited from California dash clinics, support groups, senior-citizen facilities and the UC Davis Alzheimer's Disease Center. All of the participants were venerable 70 or older. Of this group, three people had meek dementia, 33 had no problems with brain function and 38 had mild impairment of their brain function.
Wednesday, 8 May 2019
The Link Between Antidepressants And Autism
The Link Between Antidepressants And Autism.
Despite some concerns to the contrary, children whose moms second-hand antidepressants during pregnancy do not appear to be at increased endanger of autism, a large restored Danish study suggests. The results, published Dec 19, 2013 in the New England Journal of Medicine, extend some reassurance. There have been some hints that antidepressants called discriminatory serotonin reuptake inhibitors (SSRIs) could be linked to autism behan aur bahi ak sath hambestri krne ki videos bodi. SSRIs are the "first-line" drug against depression, and incorporate medications such as fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa) and paroxetine (Paxil).
In one current US study, mothers' SSRI use during pregnancy was tied to a twofold increase in the advantage that her child would have autism. A Swedish study saw a similar pattern, though the risk linked to the drugs was smaller. But both studies included only secondary numbers of children who had autism and were exposed to antidepressants in the womb spain. The imaginative study is "the largest to date" to look at the issue, using records for more than 600000 children born in Denmark, said outstrip researcher Anders Hviid, of the Statens Serum Institute in Copenhagen.
And overall, his set found, there was no clear link between SSRI use during pregnancy and children's autism risk. Hviid cautioned that the declaration is still based on a small total of children who had autism and prenatal exposure to an SSRI - 52, to be exact. The researchers notable that it's not possible to rule out a small increase in autism risk. "At this point, I do not dream this potential association should feature prominently when evaluating the risks and benefits of SSRI use in pregnancy".
Commenting on the findings, Christina Chambers, maestro of the Center for the Promotion of Maternal Health and Infant Development at the University of California, San Diego, stated, "I consider this study is reassuring". One "important" item is that the researchers factored in mothers' mental health diagnoses - which ranged from unhappiness to eating disorders to schizophrenia. "How much of the risk is related to the medication, and how much is correlated to the underlying condition? It's hard to tease out".
Despite some concerns to the contrary, children whose moms second-hand antidepressants during pregnancy do not appear to be at increased endanger of autism, a large restored Danish study suggests. The results, published Dec 19, 2013 in the New England Journal of Medicine, extend some reassurance. There have been some hints that antidepressants called discriminatory serotonin reuptake inhibitors (SSRIs) could be linked to autism behan aur bahi ak sath hambestri krne ki videos bodi. SSRIs are the "first-line" drug against depression, and incorporate medications such as fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa) and paroxetine (Paxil).
In one current US study, mothers' SSRI use during pregnancy was tied to a twofold increase in the advantage that her child would have autism. A Swedish study saw a similar pattern, though the risk linked to the drugs was smaller. But both studies included only secondary numbers of children who had autism and were exposed to antidepressants in the womb spain. The imaginative study is "the largest to date" to look at the issue, using records for more than 600000 children born in Denmark, said outstrip researcher Anders Hviid, of the Statens Serum Institute in Copenhagen.
And overall, his set found, there was no clear link between SSRI use during pregnancy and children's autism risk. Hviid cautioned that the declaration is still based on a small total of children who had autism and prenatal exposure to an SSRI - 52, to be exact. The researchers notable that it's not possible to rule out a small increase in autism risk. "At this point, I do not dream this potential association should feature prominently when evaluating the risks and benefits of SSRI use in pregnancy".
Commenting on the findings, Christina Chambers, maestro of the Center for the Promotion of Maternal Health and Infant Development at the University of California, San Diego, stated, "I consider this study is reassuring". One "important" item is that the researchers factored in mothers' mental health diagnoses - which ranged from unhappiness to eating disorders to schizophrenia. "How much of the risk is related to the medication, and how much is correlated to the underlying condition? It's hard to tease out".
Subscribe to:
Posts (Atom)